The 10 key blood components of TMYXP mainly regulate hub genes CASP3, TGFB1, PTGS2, CXCL8, FAS and JAK2, mediating various mechanisms for the treatment of CHD. This evidence concerns the gene PTGS2 and coronary artery disorder.